Scinovex
article Open AccessTop 10% cited

Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy

Frontiers in Physiology · 2012 · Vol. 3 · pp. 359–359
S. Rubina BaglioD. Michiel PegtelNicola Baldini

Abstract

Mesenchymal stem cells (MSCs) are adult multipotent cells that give rise to various cell types of the mesodermal germ layer. MSCs are of great interest in the field of regenerative medicine and cancer therapy because of their unique ability to home to damaged and cancerous tissue. These cells also regulate the immune response and contribute to reparative processes in different pathological conditions, including musculoskeletal and cardiovascular diseases. The use of MSCs for tissue repair was initially based on the hypothesis that these cells home to and differentiate within the injured tissue into specialized cells. However, it now appears that only a small proportion of transplanted MSCs actually integrate and survive in host tissues. Thus, the predominant mechanism by which MSCs participate in tissue repair seems to be related to their paracrine activity. Indeed, MSCs provide the microenvironment with a multitude of trophic and survival signals including growth factors and cytokines. Recent discoveries suggest that lipid microvesicles released by MSCs may also be important in the physiological function of these cells. Over the past few years the biological relevance of micro- and nano-vesicles released by cells in intercellular communication has been established. Alongside the conventional mediators of cell secretome, these sophisticated nanovesicles transfer proteins, lipids and, most importantly, various forms of RNAs to neighboring cells, thereby mediating a variety of biological responses. The physiological role of MSC-derived vesicles (MSC-MVs) is currently not well understood. Nevertheless, encouraging results indicate that MSC-MVs have similar protective and reparative properties as their cellular counterparts in tissue repair and possibly anti-cancer therapy. Thus, MSC-MVs represent a promising opportunity to develop novel cell-free therapy approaches that might overcome the obstacles and risks associated with the use of native or engineered stem cells.

Extracellular vesicles in diseaseRNA Interference and Gene DeliveryMesenchymal stem cell researchMesenchymal stem cellMicrovesiclesCell biologyParacrine signallingRegenerative medicineBiologyStem cellCell typeExosomeCell therapy

Funding

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Fondazione Italiana per la Ricerca sul Cancro
Citations
563
FWCI
10.20
field-weighted impact
References
130
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.